Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report

Sinonasal squamous cell carcinoma (SNSCC) is the most common, high-aggressive sinonasal malignancies that have remained relatively stable poor outcomes over the past decade. As a first-line treatment for SNSCC, surgery plus adjuvant radiotherapy is recommended. However, complete surgical resection m...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Fang Chen, Hongzheng Zhang, Yonghe Li, Tingfeng Liang, Tao Zhang
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2024-07-01
Σειρά:	Frontiers in Immunology
Θέματα:	sinonasal squamous cell carcinoma tislelizumab immune checkpoint inhibitor immunotherapy pathological complete response
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1414529/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!